Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

203,093 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.
Wang F, Zhang G, Xu T, Ma J, Wang J, Liu S, Tang Y, Jin S, Li J, Xing N. Wang F, et al. Among authors: wang j. J Exp Clin Cancer Res. 2024 Jan 20;43(1):24. doi: 10.1186/s13046-024-02955-7. J Exp Clin Cancer Res. 2024. PMID: 38245792 Free PMC article.
ILT4 facilitates angiogenesis in non-small cell lung cancer.
Wang S, Wang J, Gong W, Zhang F, Chen X, Xu H, Han Y, Fu X, Wang L, Li J, Gao A, Sun Y. Wang S, et al. Among authors: wang l, wang j. Cancer Sci. 2024 May;115(5):1459-1475. doi: 10.1111/cas.16126. Epub 2024 Mar 3. Cancer Sci. 2024. PMID: 38433526 Free PMC article.
A Systematic Study on Zinc-Related Metabolism in Breast Cancer.
Qu Z, Liu Q, Kong X, Wang X, Wang Z, Wang J, Fang Y. Qu Z, et al. Among authors: wang x, wang z, wang j. Nutrients. 2023 Mar 31;15(7):1703. doi: 10.3390/nu15071703. Nutrients. 2023. PMID: 37049543 Free PMC article. Review.
Anlotinib plus icotinib as a potential treatment option for EGFR-mutated advanced non-squamous non-small cell lung cancer with concurrent mutations: final analysis of the prospective phase 2, multicenter ALTER-L004 study.
Zhang L, Wang L, Wang J, Chen J, Meng Z, Liu Z, Jiang X, Wang X, Huang C, Chen P, Liang Y, Jiang R, Wang J, Zhong D, Shang Y, Zhang Y, Zhang C, Huang D. Zhang L, et al. Among authors: wang x, wang l, wang j. Mol Cancer. 2023 Aug 5;22(1):124. doi: 10.1186/s12943-023-01823-w. Mol Cancer. 2023. PMID: 37543587 Free PMC article. Clinical Trial.
203,093 results
You have reached the last available page of results. Please see the User Guide for more information.